Trinity Biotech (TRIB) Interest Coverage Ratio (2009 - 2024)
Trinity Biotech (TRIB) posted quarterly Interest Coverage Ratio of 2.69 for Q4 2024, down 66.2% year-on-year from 7.95 in Q1 2024, and down 424.01% on a QoQ basis from 0.83 in Q3 2024.
Trinity Biotech (TRIB) Interest Coverage Ratio (2009 - 2024) Analysis & Trends
Trinity Biotech (TRIB) has reported Interest Coverage Ratio for 16 consecutive years, with 2.69 the latest figure, recorded in Q4 2024.
- Quarterly Interest Coverage Ratio fell 66.2% year-over-year to 2.69 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 11.14 (up 164.53% YoY) and the FY2025 annual result came in at 0.74, up 66.64% from the prior year.
- Interest Coverage Ratio eased to 2.69 in Q4 2024 per TRIB's latest filing, from 0.83 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for TRIB reached as high as 11.52 in Q1 2024 and fell as low as 7.48 in Q3 2020.
- A 5-year average of 0.21 and a median of 0.17 in 2021 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio plunged 1715.44% — and 2023, when it soared 1642.96%.
- Year by year, Interest Coverage Ratio stood at 7.41 in 2020, then soared by 97.47% to 0.19 in 2021, then tumbled by 1715.44% to 3.41 in 2022, then jumped by 52.52% to 1.62 in 2023, then plunged by 66.2% to 2.69 in 2024.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 2.69, 0.83, and 1.43 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 82.35 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -2.90 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.36 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.69 |
| Sep 30, 2024 | 0.83 |
| Jun 30, 2024 | 1.43 |
| Mar 31, 2024 | 11.52 |
| Dec 31, 2023 | -1.62 |
| Sep 30, 2023 | 1.89 |
| Jun 30, 2023 | 3.88 |
| Mar 31, 2023 | 1.54 |
| Dec 31, 2022 | -3.41 |
| Sep 30, 2022 | 3.72 |
| Jun 30, 2022 | 0.22 |
| Mar 31, 2022 | 0.10 |
| Dec 31, 2021 | -0.19 |
| Sep 30, 2021 | -2.03 |
| Jun 30, 2021 | -0.16 |
| Mar 31, 2021 | -2.54 |
| Dec 31, 2020 | -7.41 |
| Sep 30, 2020 | -7.48 |
| Jun 30, 2020 | -0.41 |
| Mar 31, 2020 | -1.37 |